Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The Efficacy and Safety of Minocycline in the Treatment of Drug-resistant Epilepsy in NORSE Patients: an Open-label, One-arm Clinical Study

NCT05958069 is registered in ClinicalTrials.gov with Xijing Hospital as lead sponsor.

NCT NCT05958069
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05958069 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The Efficacy and Safety of Minocycline in the Treatment of Drug-resistant Epilepsy in NORSE Patients: an Open-label, One-arm Clinical Study
Lead sponsor
Xijing Hospital
Phase
Not applicable
Overall status
Unknown status
Start date
March 1, 2023
Completion date
March 1, 2025
Enrollment
25 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

epileptic seizures related to drugs